We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 381

Federal Circuit judges disagree on use of post filing date evidence of nonobviousness

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 21 2014

On October 20, 2014, the Federal Circuit issued an order denying the petition for rehearing or rehearing en banc filed in Bristol-Meyers Squibb Co. v

Myriad’s continuing patent debate

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 20 2014

On October 6, 2014, the U.S. Court of Appeals for the Federal Circuit entertained oral argument in the interlocutory appeal of the district court's

PTAB requires additional showing for cross-examination if testimony was prepared for another proceeding

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 16 2014

A recent order from the Patent Trial and Appeal Board ("Board") in an inter partes review illustrates how the Board may handle situations where a

Federal Circuit jurisdiction over patent contract disputes

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 9 2014

In a precedential order issued in Jang v. Boston Scientific Corp., the Federal Circuit held that it has jurisdiction over the parties' patent-related

Attorneys' fees awarded to small business patent owner to advance considerations of "compensation and deterrence"

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 8 2014

A recent case in the District of Connecticut demonstrates that courts may be more willing to award attorneys' fees to a small plaintiff, encouraging

Federal Circuit hears arguments in other Myriad gene patents case

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 7 2014

On October 6, 2014, the Federal Circuit heard oral arguments in a case involving the claims of the Myriad gene patents that were not invalidated by

Federal Circuit upholds inequitable conduct post Therasense for withheld information

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 2 2014

In American Calcar, Inc. v. American Honda Motor Co., the Federal Circuit upheld the district court’s finding that three Calcar patents are

Myriad set for another round

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 29 2014

On Monday October 6th, the U.S. Court of Appeals for the Federal Circuit will entertain oral argument in another case involving Myriad's BRCA1BRCA2

Federal Circuit applies "searching review" of stay pending CBM proceeding

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 29 2014

In Benefit Funding Systems, LLC v. Advance America Cash Advance Centers, Inc., the Federal Circuit upheld the district court's decision to stay

Irreparable harm no longer presumed in the Third Circuit for Lanham Act plaintiffs

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 23 2014

In a recent decision, the Court of Appeals for the Third Circuit eliminated the presumption of irreparable harm for Lanham Act plaintiffs seeking